Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience.

Nonparametric Estimation from Incomplete Observations

1992 • 45,923 citations

Regression Models and Life-Tables

1992 • 27,454 citations

Effect of Enalapril on Survival in Patients with Reduced Left Ventricular Ejection Fractions and Congestive Heart Failure

1991 • 8,296 citations

Asymptotically Efficient Rank Invariant Test Procedures

1972 • 3,392 citations

Late Cardiac Effects of Doxorubicin Therapy for Acute Lymphoblastic Leukemia in Childhood

1991 • 1,386 citations

Dangers of Using "Optimal" Cutpoints in the Evaluation of Prognostic Factors

1994 • 1,107 citations

Cardiac Toxicity 4 to 20 Years After Completing Anthracycline Therapy

1991 • 934 citations

Cardiovascular Health and Disease in Women

1993 • 803 citations

Female Sex and Higher Drug Dose as Risk Factors for Late Cardiotoxic Effects of Doxorubicin Therapy for Childhood Cancer

1995 • 766 citations

Triceps skin fold and upper arm muscle size norms for assessment of nutritional status1,2

1974 • 524 citations

The thyroid and the heart.

1993 • 473 citations

Multimodal therapy for the management of nonpelvic, localized Ewing's sarcoma of bone: intergroup study IESS-II.

1990 • 388 citations

The impact of childhood cancer on the United States and the world

1990 • 380 citations

Cyclophosphamide cardiotoxicity in bone marrow transplantation: a prospective evaluation of new dosing regimens.

1991 • 329 citations

Influence of Doxorubicin Dose Intensity on Response and Outcome for Patients With Osteogenic Sarcoma and Ewing's Sarcoma

1991 • 206 citations

Doxorubicin clearance in the obese.

1988 • 204 citations

Cyclophosphamide pharmacokinetics: correlation with cardiac toxicity and tumor response.

1992 • 193 citations

Electrocardiographic changes and arrhythmias after cancer therapy in children and young adults

1992 • 188 citations

Initial congestive heart failure, six to ten years after doxorubicin chemotherapy for childhood cancer

1990 • 170 citations

Sleep related upper airway obstruction in a cohort with Down's syndrome.

1991 • 167 citations

Dobutamine stress echocardiography: A sensitive indicator of diminished myocardial function in asymptomatic doxorubicin-treated long-term survivors of childhood cancer

1992 • 137 citations

Common Syndromes and Management Issues for Primary Care Physicians

1991 • 116 citations

Cardiac function in Wilms' tumor survivors.

1995 • 94 citations

Functional myocardial impairment in children treated with anthracyclines for cancer

1991 • 88 citations

Alveolar Hypoventilation and Cor Pulmonale Associated with Chronic Airway Obstruction in Infants with Down Syndrome

1982 • 87 citations

The impact of induction anthracycline on long‐term failure‐free survival in childhood acute lymphoblastic leukemia

1986 • 80 citations

Exercise echocardiography in the detection of anthracycline cardiotoxicity

1991 • 77 citations

Long term doxorubicin cardiotoxicity in childhood: non-invasive evaluation of the contractile state and diastolic filling.

1988 • 64 citations

Pulmonary hypertension and congestive heart failure in children with chronic upper airway obstruction

1969 • 60 citations

Predictors of Mortality from Idiopathic Dilated Cardiomyopathy in 356,222 Men Screened for the Multiple Risk Factor Intervention Trial

1994 • 58 citations

THE EPIDEMIOLOGY OF IDIOPATHIC DILATED CARDIOMYOPATHY IN A BIRACIAL COMMUNITY

1990 • 50 citations

Gender difference in aerobic capacity in adolescents after cure from malignant disease in childhood

1993 • 50 citations

Cardiac dysfunction late after cardiotoxic therapy for childhood cancer

1994 • 48 citations

Hypertensive pulmonary vascular disease in Down syndrome

1979 • 41 citations

Black-White Differences in Idiopathic Dilated Cardiomyopathy

1993 • 36 citations

Perioperative complications in patients with anthracycline chemotherapeutic agents

1985 • 32 citations

Cardiac abnormalities after AMSA administration.

1982 • 30 citations

Black-white differences in mortality in idiopathic dilated cardiomyopathy: the Washington, DC, dilated cardiomyopathy study.

1994 • 30 citations

Mitoxantrone and cyclophosphamide in advanced breast cancer: a pilot study.

1984 • 26 citations

Tissue disposition of doxorubicin in experimental animals

1982 • 23 citations

Amsacrine is safe and effective therapy for patients with myocardial dysfunction and acute leukemia

1991 • 23 citations

Effects of treatment for childhood cancer on vital organ systems

1993 • 21 citations

Phase II study of 4'-(9-acridinylamino)methanesulfon-m-anisidide (NSC 249992) in children with acute leukemia and lymphoma.

1982 • 17 citations

Evaluation of AMSA in children with acute leukemia. A pediatric oncology group study

1984 • 15 citations

Plasma and Tissue Distribution of Adriamycin in Patients with Pelvic Cancer

1981 • 13 citations

Myocardial toxicity of high-dose cyclophosphamide in rabbits treated with daunorubicin

1991 • 8 citations